Dale C. Van Demark and Sarah T. Hogan will speak at Mergermarket’s Annual Life Sciences and Healthcare M&A Forum.

Topics will include:

• Exit opportunities for older fund vintages over the next 6-18 months
• Forecast 2017/18 dry powder deployment, sector economics and exit conditions
• When does private placement financing make sense? Prior to IPO or strategic sale?
• Challenges ahead in prepping portfolio companies for publicly traded life
• Considering recent product development failures and a thin product pipeline among biotech companies, how are portfolio managers positioning these investments?